Dual delivery of placental growth factor and vascular endothelial growth factor from poly(hydroxyethyl methacrylate-co-methyl methacrylate) microcapsules containing doubly transfected luciferase-expressing L929 cells

Tissue Engineering - Part A

Volumn 15, Issue 8, 2009, Pages 1929-1939

  Cheng, Dangxiao ^a   Sefton, Michael V ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

BIOACTIVITY; BIOMATERIALS; CELL CULTURE; ENDOTHELIAL CELLS; ESTERS; FLOW CYTOMETRY; IMMUNOLOGY; PEPTIDES; SELF ASSEMBLY;

ADAPTIVE IMMUNE RESPONSE; ANIMAL MODEL; CONTROL GROUPS; DOSE-DEPENDENT; ENCAPSULATED CELL; GROWTH FACTOR; HOST RESPONSE; HYDROXYETHYL METHACRYLATE; IMMUNE RESPONSE; LUCIFERASE EXPRESSION; MAJOR HISTOCOMPATIBILITY COMPLEX; METHYL METHACRYLATES; MICROCAPSULES; MOUSE-FIBROBLASTS; TO EFFECT; TRANSFECTED CELLS; VASCULAR ENDOTHELIAL GROWTH FACTOR; VASCULARIZATION;

CELL MEMBRANES;

ALLOANTIGEN; CD3 ANTIGEN; COPOLYMER; LUCIFERASE; MATRIGEL; PLACENTAL GROWTH FACTOR; POLY(HYDROXYETHYL METHACRYLATE CO METHYL METHACRYLATE); UNCLASSIFIED DRUG; VASCULOTROPIN;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL ENCAPSULATION; CELL STRAIN L 929; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GENETIC TRANSFECTION; HISTOLOGY; IMMUNOMODULATION; IMPLANT; MAJOR HISTOCOMPATIBILITY COMPLEX; MICROCAPSULE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VASCULARIZATION;

ANIMALIA; MUS;

ANIMALS; ANTIBODIES; ANTIGENS, CD3; CAPSULES; CELL LINE; COLLAGEN; DRUG COMBINATIONS; DRUG DELIVERY SYSTEMS; GENE EXPRESSION; IMPLANTS, EXPERIMENTAL; LAMININ; LUCIFERASES; METHYLMETHACRYLATES; MICE; NEOVASCULARIZATION, PHYSIOLOGIC; POLYHYDROXYETHYL METHACRYLATE; POLYMETHACRYLIC ACIDS; PREGNANCY PROTEINS; PROTEOGLYCANS; TISSUE DONORS; TITRIMETRY; TRANSFECTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; WHOLE BODY IMAGING;

EID: 68749095865     PISSN: 19373341     EISSN: 1937335X     Source Type: Journal    
DOI: 10.1089/ten.tea.2008.0470     Document Type: Article

References (27)

1. Lahooti, S., Sefton, M.V. Agarose enhances the viability of intraperitoneally implanted microencapsulated L929 fibroblasts. Cell Transplant 9, 785, 2000.
2. Vallbacka, J.J., Sefton, M.V. Vascularization and improved in vivo survival of VEGF-secreting cells microencapsulated in HEMA-MMA. Tissue Eng 13, 2259, 2007.
3. Cheng, D., Lo, C., Sefton, M.V. Effect of mouse VEGF 164 on the viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated cells in vivo: Bioluminescence imaging. J Biomed Mater Res A 87, 321, 2008.
4. Park, J.E., Chen, H.H., Winer, J., Houck, K.A., Ferrara, N. Placenta growth factor. Potentiation of vascular endothelial growth factor bioactivity, in vitro and in vivo, and high affinity binding to Flt-1 but not to Flk-1/KDR. J Biol Chem 269, 25646, 1994.
5. Autero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F., Kliche, S., Fellbrich, G., Ballmer-Hofer, K., Maglione, D., Mayr-Beyrle, U., Dewerchin, M., Dombrwski, S., Stanimirovic, D., Van Hummelen, P., Dehio, C., Hicklin, D.J., Persico, G., Herbert, J.M., Communi, D., Shibuya, M., Collen, D., Conway, E.M., Carmeliet, P. Role of PlGF in the intra and intermolecular cross talk between the VEGF receptors Flt1 and Flk1. Nat Med 9, 936, 2003.
6. Auriero, M., Luttun, A., Tjwa, M., Carmeliet, P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: Novel targets for stimulation of ischemic tissue and inhibition of angiogenic and inflammatory disorder. J Thromb Haemost 1, 1356, 2003.
7. Pipp, F., Heil, M., Issvrucker, K., Ziegelhoeffer, T., Martin, S., Van Den Heuvel, J., Weich, H., Fernandez, B., Golomb, G., Carmeliet, P., Schaper, W., Clauss, M. VEGFR-1 selective VEGF homologue PlGF is arteriogenic: Evidence for a monobyte-mediated mechanism. Circ Res 92, 378, 2003.
8. Nagy, J.A., Dvorak, A.M., Dvorak, H.F. VEGF-A164/165 and PlGF: roles in angiogenesis and arteriogenesis. Trends Cardiovasc Med. 13, 169, 2003.
9. Kolakowski Jr, S., Berry, M.F., Atluri, P., Grand, T., Fisher, O., Astrid Moise, S.M., Cohen, J., Hsu, V., Woo, Y.J. Placental growth factor provides a novel local angiogenic therapy for ischemic cardiomyopathy. J Card Surg 2006;21:559-564.
10. Cianfarani, F., Zambruno, G., Brogelli, L., Sera, F., Lacal, PM., Pesce, M., Capogrossi, MC., Failla, CM., Napolitano, M., Odorisio, T. Placenta growth factor in diabetic wound healing: altered expression and therapeutic potential. Am J Pathol 169, 1167, 2006.
11. Surzyn, M., Symes, J., Medin, J.A., Sefton, M.V. IL-10 secretion increases signal persistence of HEMA-MMA microencapsulated luciferase-modified CHO fibroblasts in mice, Tissue Eng 2008 Aug 18. [Epub ahead of print].
12. Lahooti, S., Sefton, M.V. Methods for microencapsulation with HEMA-MMA. In: Morgan, J.R., Yarmush, M.L., eds. Methods in Molecular Medicine, Vol. 18: Tissue Engineering Methods and Protocols. Totowa, NJ: Humana Press, 1998, pp. 331-348.
13. Fleming, A.J., Sefton, M.V. Viability of hydroxyethyl methacrylate-methyl methacrylate-microencapsulated PC12 cells after omental pouch implantation within agarose gels. Tissue Eng 9, 1023, 2003.
14. Jones, K.S., Sefton, M.V., Gorczynski, R.M. In vivo recognition by the host adaptive immune system of microencapsulated xenogeneic cells. Transplantation 78, 1454, 2004.
15. Cao, R., Brakenhielm, E., Pawliuk, R., Wariaro, D., Post, M.J., Wahlberg, E., Leboulch, P., Cao, Y. Angiogenic synergism, vascular stability and improvement of hind-limb ischemia by a combination of PDGF-BB and FGF-2. Nat Med 9, 604, 2003.
16. Nillesen, S.T., Geutjes, P.J., Wismans, R., Schalkwijk, J., Daamen, W.F., van Kuppevelt, T.H. Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 28, 1123, 2007.
17. Chen, R.R., Silva, E.A., Yuen, W.W., Mooney, D.J. Spatiotemporal VEGF and PDGF delivery patterns blood vessel formation and maturation. Pharm Res 24, 258, 2007.
18. Zheng, Y., Murakami, M., Takahashi, H., Yamauchi, M., Kiba, A., Yamaguchi, S., Yabana, N., Alitalo, K., Shibuya, M. Chimeric VEGF-ENZ7/PlGF promotes angiogenesis via VEGFR-2 without significant enhancement of vascular permeability and inflammation. Arterioscler Thromb Vasc Biol 26, 2019, 2006.
19. Inoue, N., Kondo, T., Kobayashi, K., Aoki, M., Numaguchi, Y., Shibuya, M., Murohara, T. Therapeutic angiogenesis using novel vascular endothelial growth factor-E/human placental growth factor chimera genes. Arterioscler Thromb Vasc Biol 27, 99, 2007.
20. Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., Scholz, D., Acker, T., DiPalma, T., Dewerchin, M., Noel, A., Stalmans, I., Barra, A., Blacher, S., Vandendriessche, T., Ponten, A., Eriksson, U., Plate, K.H., Foidart, J.M., Schaper, W., Charnock-Jones, D.S., Hicklin, D.J., Herbert, J.M., Collen, D., Persico, M.G. Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathological conditions. Nat Med 7, 575, 2001.
21. Autiero, M., Luttun, A., Tjwa, M., Carmeliet, P. Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders J Thromb Haemost 1, 1356, 2003.
22. Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J.A., Hooper, A., Priller, J., De Klerck, B., Compernolle, V., Daci, E., Bohlen, P., Dewerchin, M., Herbert, JM., Fava, R., Matthys, P., Carmeliet, G., Collen, D., Dvorak, HF., Hicklin, DJ., Carmeliet, P. Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8, 831, 2002.
23. Odorisio, T., Schietroma, C., Zaccaria, ML., Cianfarani, F., Tiveron, C., Tatangelo, L., Failla, C.M., Zambruno, G. Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability. J Cell Sci 115, 2559, 2002.
24. Yancopoulos, G.D., Davls, S., Gale, N.W., Rudge, J.S., Wiegand, S.J., Holash, J. Vascular-specific growth factors and blood vessel formation. Nature. 407, 242, 2000.
25. Pandya, N.M., Dhalla, N.S., Santani, D.D. Angiogenesis - a new target for future therapy. Vascul Pharmacol 44, 265, 2006.
26. Heimrich, B., Schwegler, H., Crusio, W.E., Buselmaier, W. Substrain divergence in C3H inbred mice. Behav Genet 18, 671, 1988.
27. Steinmuller, D., Tyler, J.D., David, C.S. Cell-mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells. II. Genetic basis of the response of C3H mice. J Immunol 126, 1754, 1981.